Eton Pharmaceuticals Inc — Cash Flow (NASDAQ:ETON) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics

Quarterly Annual

Cash from operating activities -22.35 M-4.72 M4.82 M6.82 M969 K10.52 M 10.52 M Cash from investing activities -50 K-2.56 M-2.79 M-775 K-40.01 M-333 K -333 K Cash from financing activities 31.63 M391 K-134 K-957 K32.59 M815 K 815 K Free cash flow -22.4 M-7.98 M2.03 M6.04 M-9.04 M10.19 M 10.19 M

Nouvelles

Tarsus Pharmaceuticals Stock Earns Upgrade To RS Rating

Arcutis Biotherapeutics Shows Market Leadership With Jump To 82 RS Rating

Eton Pharmaceuticals (ETON) Soars 6.7%: Is Further Upside Left in the Stock?

Dow Jones Futures: Trump's Iran Comments Spark Stock Market Rally; Micron, Nvidia, Palantir, Tesla Are Big Movers

Stock Market Today: Dow Up As These Leisure Plays Cruise Higher; Pharma Stock Clears Entry (Live Coverage)

H.C. Wainwright relève l’objectif de cours d’Eton Pharmaceuticals

B.Riley relève l’objectif de cours d’Eton Pharmaceuticals après de solides résultats T4

Eton Pharmaceuticals, Inc. (ETON) Q4 2025 Earnings Call Transcript

Eton Pharmaceuticals dépasse les attentes de BPA au T4 2025

Eton Pharmaceuticals, Inc. (ETON) Q4 Earnings Lag Estimates

Le BPA de Eton Pharmaceuticals a dépassé les attentes de 0,01$, le CA en dessous des prévisions

Ovid Therapeutics (OVID) Q4 Earnings and Revenues Surpass Estimates